[Federal Register: November 28, 2003 (Volume 68, Number 229)]
[Notices]
[Page 66829-66834]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr28no03-67]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Cooperative Agreement for Research on the Association Between
Exposure to Media Violence and Youth Violence
Announcement Type: New.
Funding Opportunity Number: 04060.
Catalog of Federal Domestic Assistance Number: 93.136.
Key Dates:
Letter of Intent Deadline: December 29, 2003.
Application Deadline: February 17, 2004.
I. Funding Opportunity Description
Authority: This program is authorized under section 301 (a) [42
U.S.C. 241(a)] of the Public Health Service Act and section 391
(a)[42 U.S.C. 280b (a)] of the Public Service Health Act, as
amended.
Purpose: The purpose of the program is to conduct methodologically
sound research on how media violence affects youth violent behavior.
This program addresses the ``Healthy People 2010'' focus area of Injury
and Violence Prevention.
Measurable outcomes of the program will be in alignment with the
following performance goal for the National Center for Injury
Prevention and Control (NCIPC): Conduct a targeted program of research
to reduce injury-related death and disability.
[[Page 66830]]
Research Objectives
There has been a longstanding concern about the consequences of
youths' exposure to violence in the media, with particular concern
about the effects of such exposure on violent behavior. Recent studies
have documented the profusion of different types of media in United
States homes \1-3\ and the widespread presence of violence in these
media outlets.\4,5\ The emergence and proliferation of new media (e.g.,
video games, music videos, Internet sites, and DVD) have increased
opportunities for children and youth to be exposed to violence. Despite
the fact that there has been extensive research on this subject, at
least three key gaps remain in our understanding of the relationship
between youth exposure to media violence and violent behavior. First,
more information is needed about the effects of different types of new
media and their content on violent behavior. Second, while substantial
research has described associations between exposure to violent media
on attitudes and measures of aggression, less is known about the extent
to which exposure to violent media is associated with risk for more
serious forms of violence, including victimization and perpetration
resulting in injury. Third, a relatively small subset of youth may be
particularly susceptible to the effects of exposure to violent media.
Additional research is needed to understand the individual and
contextual factors that influence the association between exposure to
violent media and risk for violence.
The purpose of the current program announcement is to conduct
methodologically sound research on how media influences youth
susceptibility to violence. Project proposals should be designed to:
(1) Examine the association between exposure to violent media and
serious violent behavior, including victimization and perpetration
resulting in injury; (2) include an assessment of the specific aspects
of media (e.g., type and content) that are likely to contribute to risk
for violence; and (3) identify individual and contextual factors that
mediate or moderate the association between exposure to violent media
and serious violent behavior, with particular attention to the
potential moderating effects of gender and prior exposure to real-life
violence.
Funding Priority
Priority will be given to research proposals that include a focus
on (a) new forms of media; (b) serious forms of violence, including
victimization and perpetration resulting in injury; and (c) describing
the individual and contextual factors that influence the association
between exposure to violent media and risk for violence.
Activities
Awardee activities for this program are as follows:
1. In collaboration with CDC finalize the research design and
methodology, data collection measures, analyses, and dissemination of
the study results through publication and presentations.
2. In collaboration with CDC finalize a research protocol for
Institutional Review Board (IRB) review by all cooperating institutions
participating in the research project.
3. Conduct one reverse site visit to meet with CDC staff in Atlanta
on an annual basis.
4. Complete all required reports as specified under ``Reporting
Requirements'' of this program announcement.
In a cooperative agreement, CDC staff is substantially involved in
the program activities, above and beyond routine grant monitoring.
CDC activities for this program are as follows:
1. Serve as co-investigator and provide scientific oversight. CDC
will actively collaborate with project staff on decision-analyses,
interpretation of findings, and dissemination of the study results
through involvement in the production of publications and
presentations.
2. Assist in finalizing the research protocol for IRB review by all
cooperating institutions participating in the research project. The CDC
IRB will review and approve the protocol initially and on at least an
annual basis until the research project is finished.
3. Facilitate regular communication between CDC and the grantee to
include, but not limited to site visits, conference calls, meetings,
etc.
II. Award Information
Type of Award: Cooperative Agreement. CDC involvement in this
program is listed in the Activities Section above.
Fiscal Year Funds: 2004.
Approximate Total Funding: $600,000.
Approximate Number of Awards: Two.
Approximate Average Award: $300,000.
Floor of Award Range: None.
Ceiling of Award Range: $300,000.
Anticipated Award Date: August 2, 2004.
Budget Period Length: 12 months.
Project Period Length: Three years.
Throughout the project period, CDC's commitment to continuation
awards will be conditioned on the availability of funds, evidence of
satisfactory progress by the recipient (as documented in required
reports), and the determination that continued funding is in the best
interest of the Federal Government.
III. Eligibility Information
1. Eligible applicants: Applications may be submitted by public and
private nonprofit organizations and by governments and their agencies,
such as:
[sbull] Public nonprofit organizations
[sbull] Private nonprofit organizations
[sbull] Small, minority, women-owned businesses
[sbull] Universities
[sbull] Colleges
[sbull] Research institutions
[sbull] Hospitals
[sbull] Community-based organizations
[sbull] Faith-based organizations
[sbull] Federally recognized Indian tribal governments
[sbull] Indian tribes
[sbull] Indian tribal organizations
[sbull] State and local governments or their bona fide agents (this
includes the District of Columbia, the Commonwealth of Puerto Rico, the
Virgin Islands, the Commonwealth of Mariana Islands, American Samoa,
Guam, the Federated States of Micronesia, the Republic of the Marshall
Islands, and the Republic of Palau)
[sbull] Political subdivisions of States (in consultation with States)
A Bona Fide Agent is an agency/organization identified by the state
as eligible to submit an application under the state eligibility in
lieu of a state application. If you are applying as a bona fide agent
of a state or local government, you must provide a letter from the
state as documentation of your status. Place this documentation behind
the first page of your application form.
2. Cost Sharing or Matching: Matching funds are not required for
this program.
3. Other Eligibility Requirements:
Applications that are incomplete or non-responsive to the below
requirements will be returned to the applicant without further
consideration. You will be notified that your application did not meet
submission requirements.
The following are applicant requirements:
1. A principal investigator who has conducted research, published
the
[[Page 66831]]
findings in peer-reviewed journals, and has specific authority and
responsibility to carry out the proposed project.
2. Demonstrated experience on the applicant's project team in
conducting, evaluating, and publishing violence prevention research in
peer-reviewed journals.
3. Effective and well-defined working relationships within the
performing organization and with outside entities, which will ensure
implementation of the proposed activities.
4. The overall match between the applicant's proposed research
objectives and the program priorities as described under the heading,
``Funding Priority''.
5. The requested funding amount should not be greater than the
ceiling of the award amount.
6. Principal investigators (PI's) are encouraged to submit only one
proposal in response to this program announcement. With few exceptions
(e.g., research issues needing immediate public health attention), only
one application per PI will be funded under this announcement.
Note: Title 2 of the United States Code section 1611 states that
an organization described in section 501(c)(4) of the Internal
Revenue Code that engages in lobbying activities is not eligible to
receive Federal funds constituting an award, grant, or loan.
IV. Application and Submission Information
1. Address to Request Application Package
To apply for this funding opportunity, use application Form PHS 398
(OMB Number 0925-0001 rev. 5/2001). Forms and instructions are
available in an interactive format on the CDC Web site, at the
following Internet address: http://www.cdc.gov/od/pgo/forminfo.htm.
Forms and instructions are also available in an interactive format
on the National Institutes of Health (NIH) web site at the following
Internet address: http://grants.nih.gov/grants/funding/phs398/phs398.html.
If you do not have access to the Internet, or if you have
difficulty accessing forms on-line, you may contact the CDC Procurement
and Grants Office Technical Information Management Section (PGO-TIM)
staff at 770-488-2700. Application forms can be mailed to you.
2. Content and Form of Application Submission Letter of Intent (LOI)
CDC requests that you send a LOI if you intend to apply for this
program. Although the LOI is not required, not binding, and does not
enter into the review of your subsequent application, the LOI will be
used to gauge the level of interest in this program, and to allow CDC
to plan the application review. Your LOI must be written in the
following format:
[sbull] Maximum number of pages: Two
[sbull] Font size: 12-point unreduced
[sbull] Paper size: 8.5 by 11 inches
[sbull] Single Spaced
[sbull] Page margin size: One inch
[sbull] Printed only on one side of page
[sbull] Written in English, avoid jargon
Your LOI must contain the following information:
[sbull] Descriptive title of the proposed research
[sbull] Name, address, E-mail address, and telephone number of the
Principal Investigator
[sbull] Names of other key personnel
[sbull] Participating institutions
[sbull] Number and title of this Program Announcement (PA)
Application: Follow the PHS 398 application instructions for
content and formatting of your application. See all attachments of this
announcement as it is posted on the CDC Web site for guidance on how to
complete Form 398 for this Program Announcement. The Program
Announcement Title and number must appear in the application. For
further assistance with the PHS 398 application form, contact GrantsInfo, Telephone (301) 435-0714, email: GrantsInfo@nih.gov.
You must include a research plan with your application. The
research plan should be no more than 25 pages (8.5'' x 11'' in size),
single-spaced, printed on one side only, with one-inch margins on all
sides, and unreduced 12-point font.
Your application will be evaluated on the criteria listed under
Section V. Application Review Information, so it is important to follow
them, as well as the Research Objectives and the Administrative and
National Policy Requirements (AR's), in laying out your research plan.
Your research plan should address activities to be conducted over the
entire project period.
The research plan should consist of the following information:
1. Abstract. Provide a one page brief description of proposed
research activities and project outcomes. It is important to include an
abstract that reflects the project's focus, because the abstract will
be used to help determine the responsiveness of the application.
2. Goals and Objectives. Describe the goals and objectives the
proposed research is designed to achieve in the short and long term.
Specific research questions and hypotheses should also be included. In
addition, the research plan should include an outline of a three-year
plan with timeline.
3. Program Participants. Describe the study population for the
proposed research and how participants will be selected (i.e., sampling
strategy). In addition, the research plan should provide evidence that
the recipient (or a collaborating partner) has access to the study
population, and that the participation by the study population will be
adequate to test hypotheses.
4. Methods. Describe the proposed study design; methods, and
analysis plan to test the proposed study hypotheses.
5. Project Management. Provide evidence of the expertise, capacity,
and existing staff necessary to successfully conduct the research. Each
existing or proposed position for the project should be described by
job title, function, general duties, level of effort and allocation of
time. Management operation principles, structure, and organization
should also be noted.
6. Collaborative Efforts. List and describe the current and
proposed collaborations with government, health, or youth agencies,
community- or faith-based organizations, minority organizations, and
other researchers. Include letters of support and memoranda of
understanding that specify the nature of past, present, and proposed
collaborations, and the products/services/activities that will be
provided by and to the applicant.
7. Data Sharing and release: Describe plans for the sharing and
release of data (See AR-25 for additional information).
8. Project Budget. Provide a detailed budget for each activity
undertaken, with accompanying justification of all operating expenses
that is consistent with the stated objectives and planned activities of
the project. This announcement does not use the modular budget format.
The budget should include at least one trip per year to CDC for program
related meetings.
You are required to have a Dun and Bradstreet Data Universal
Numbering System (DUNS) number to apply for a grant or cooperative
agreement from the Federal government. Your DUNS number must be entered
in item 11 of the face page of the PHS 398 application form. The DUNS
number is a nine-digit identification number, which uniquely identifies
business entities. Obtaining a DUNS number is easy and there is no
charge. To obtain a DUNS number, access http://www.dunandbradstreet.com
or call 1-866-705-5711. For more information, see the CDC Web site at:
http://www.cdc.gov/od/pgo/funding/pubcommt.htm.
[[Page 66832]]
3. Submission Dates and Times
LOI Deadline Date: December 29, 2003.
Application Deadline Date: February 17, 2004.
Explanation of Deadlines: Applications must be received in the CDC
Procurement and Grants Office by 4 p.m. Eastern Time on the deadline
date. If you send your application by the United States Postal Service
or commercial delivery services, you must ensure that the carrier will
be able to guarantee delivery of the application by the closing date
and time. If an application is received after closing due to (1)
carrier error, when the carrier accepted the package with a guarantee
for delivery by the closing date and time, or (2) significant weather
delays or natural disasters, CDC will upon receipt of proper
documentation, consider the application as having been received by the
deadline.
This announcement is the definitive guide on application submission
address and deadline. It supersedes information provided in the
application instructions. If your application does not meet the
deadline above, it will not be eligible for review, and will be
discarded. You will be notified that you did not meet the submission
requirements.
CDC will not notify you upon receipt of your application. If you
have a question about the receipt of your application, first contact
your courier. If you still have any questions, contact the PGO-TIM
staff at: 770-488-2700. Before calling, please wait two to three days
after the application deadline. This will allow time for applications
to be processed and logged.
4. Intergovernmental Review: Executive Order 12372 does not apply
to this program.
5. Funding Restrictions: Restrictions, which must be taken into
account while writing your budget, are as follows: None
If you are requesting indirect costs in your budget, you must
include a copy of your indirect cost rate agreement. If your indirect
cost rate is a provisional rate, the agreement must be less than 12
months of age.
Awards will not allow reimbursement of pre-award costs.
6. Other Submission Requirements
LOI Submission Address: Submit your LOI by express mail, delivery
service, fax, or E-mail to: Robin Forbes, National Center for Injury
Prevention and Control, Centers for Disease Control and Prevention,
4770 Buford Hwy, NE., Mailstop K-62, Atlanta, GA 30341, Fax: 770-488-1662. Telephone: 770-488-4037. Email: CIPERT@cdc.gov.
Application Submission Address: Submit the signed original and five
copies of your application by mail or express delivery to: Technical
Information Management--PA 04060, Procurement and Grants
Office, Centers for Disease Control and Prevention, 2920 Brandywine
Road, Atlanta, GA 30341.
Applications may not be submitted electronically at this time.
V. Application Review Information
1. Criteria: You are required to provide measures of effectiveness
that will demonstrate the accomplishment of the various identified
objectives of the cooperative agreement. Measures of effectiveness must
relate to the performance goals stated in the ``Purpose'' section of
this announcement. Measures must be objective and quantitative, and
must measure the intended outcome. These measures of effectiveness must
be submitted with the application and will be an element of evaluation.
The goals of CDC-supported research are to advance the
understanding of biological systems, improve the control and prevention
of disease, and enhance health. In the written comments, reviewers will
be asked to evaluate the application in order to judge the likelihood
that the proposed research will have a substantial impact on the
pursuit of these goals. The scientific review group will address and
consider each of the following criteria in assigning the application's
overall score, weighting them as appropriate for each application.
The application does not need to be strong in all categories to be
judged likely to have major scientific impact and thus serve a high
priority score. For example, an investigator may propose to carry out
important work that by its nature is not innovative, but is essential
to move a field forward.
The criteria are as follows:
Significance: Does this study address an important problem? If the
aims of the application are achieved, how will scientific knowledge be
advanced? What will be the effect of these studies on the concepts or
methods that drive this field?
Approach: Are the conceptual framework, design, methods, and
analyses adequately developed, scientifically rigorous, well-
integrated, and appropriate to the aims of the project? Does the
applicant acknowledge potential problem areas and consider alternative
tactics?
Innovation: Does the project employ novel concepts, approaches or
methods? Are the aims original and innovative? Does the project
challenge existing paradigms or develop new methodologies or
technologies?
Investigator: Is the investigator appropriately trained and well
suited to carry out this work? Is the work proposed appropriate to the
experience level of the principal investigator and other researchers
(if any)?
Environment: Does the scientific environment in which the work will
be done contribute to the probability of success? Does the proposed
research take advantage of unique features of the scientific
environment or employ useful collaborative arrangements? Is there
evidence of institutional support?
Additional Review Criteria:
Protection of Human Subjects from Research Risks: Does the
application adequately address the requirements of Title 45 CFR Part 46
for the protection of human subjects? This will not be scored, however,
an application can be disapproved if the research risks are
sufficiently serious and protection against risks is so inadequate as
to make the entire application unacceptable.
Inclusion of Women and Minorities in Research: Does the application
adequately address the CDC Policy requirements regarding the inclusion
of women, ethnic, and racial groups in the proposed research? This
includes: (1) The proposed plan for the inclusion of both sexes and
racial and ethnic minority populations for appropriate representation;
(2) The proposed justification when representation is limited or
absent; (3) A statement as to whether the design of the study is
adequate to measure differences when warranted; and (4) A statement as
to whether the plans for recruitment and outreach for study
participants include the process of establishing partnerships with
community(ies) and recognition of mutual benefits.
Inclusion of Children as Participants in Research Involving Human
Subjects:
The NIH maintains a policy that children (i.e., individuals under
the age of 21) must be included in all human subjects research,
conducted or supported by the NIH, unless there are scientific and
ethical reasons not to include them. This policy applies to all initial
(Type 1) applications submitted for receipt dates after October 1,
1998.
All investigators proposing research involving human subjects
should read the ``NIH Policy and Guidelines'' on the inclusion of
children as participants in research involving human subjects that is
available at: http://grants.nih.gov/grants/funding/children/children.htm
.
[[Page 66833]]
Budget: The reasonableness of the proposed budget and the requested
period of support in relation to the proposed research.
2. Review and Selection Process: Applications will be reviewed for
completeness by the Procurement and Grants Office (PGO) and for
responsiveness by the NCIPC. Incomplete applications and applications
that are non-responsive will not advance through the review process.
Applicants will be notified that their application did not meet
submission requirements.
Applications that are complete and responsive to the PA will be
subjected to a preliminary evaluation (streamline review) by a peer
review committee, the Initial Review Group (IRG) convened by NCIPC, to
determine if the application is of sufficient technical and scientific
merit to warrant further review by the IRG. CDC will withdraw from
further consideration applications judged to be noncompetitive and
promptly notify the principal investigator or program director and the
official signing for the applicant organization. Those applications
judged to be competitive will be further evaluated by a dual review
process.
1. The primary review will be a peer review conducted by the IRG.
All applications will be reviewed for scientific merit in accordance
with the review criteria listed above. Applications will be assigned a
priority score based on the National Institutes of Health (NIH) scoring
system of 100-500 points.
2. The secondary review will be conducted by the Science and
Program Review Subcommittee (SPRS) of NCIPC's Advisory Committee for
Injury Prevention and Control (ACIPC). The ACIPC Federal agency experts
will be invited to attend the secondary review, and will receive
modified briefing books (i.e., abstracts, strengths and weaknesses from
summary statements, and project officer's briefing materials). ACIPC
Federal agency experts will be encouraged to participate in
deliberations when applications address overlapping areas of research
interest, so that unwarranted duplication in federally-funded research
can be avoided and special subject area expertise can be shared. The
NCIPC Division Associate Directors for Science (ADS) or their designees
will attend the secondary review in a similar capacity as the ACIPC
Federal agency experts to assure that research priorities of the
announcement are understood and to provide background regarding current
research activities. Only SPRS members will vote on funding
recommendations, and their recommendations will be carried to the
entire ACIPC for voting by the ACIPC members in closed session. If any
further review is needed by the ACIPC, regarding the recommendations of
the SPRS, the factors considered will be the same as those considered
by the SPRS.
The committee's responsibility is to develop funding
recommendations for the NCIPC Director based on the results of the
primary review, the relevance and balance of proposed research relative
to the NCIPC programs and priorities, and to assure that unwarranted
duplication of federally-funded research does not occur. The secondary
review committee has the latitude to recommend to the NCIPC Director,
to reach over better-ranked proposals in order to assure maximal impact
and balance of proposed research. The factors to be considered will
include:
a. The results of the primary review including the application's
priority score as the primary factor in the selection process.
b. The relevance and balance of proposed research relative to the
NCIPC programs and priorities.
c. The significance of the proposed activities in relation to the
priorities and objectives stated in ``Healthy People 2010,'' the
Institute of Medicine report, ``Reducing the Burden of Injury,'' and
the ``CDC Injury Research Agenda.''
All awards will be determined by the Director of the NCIPC based on
priority scores assigned to applications by the IRG, recommendations by
the secondary review committee, e.g., NCIPC's Advisory Committee for
Injury Prevention and Control (ACIPC), consultation with NCIPC senior
staff, and the availability of funds.
VI. Award Administration Information
1. Award Notices: Successful applicants will receive a Notice of
Grant Award (NGA) from the CDC Procurement and Grants Office. The NGA
shall be the only binding, authorizing document between the recipient
and CDC. The NGA will be signed by an authorized Grants Management
Officer, and mailed to the recipient fiscal officer identified in the
application.
2. Administrative and National Policy Requirements:
45 CFR Part 74 and 92
For more information on the Code of Federal Regulations, see the
National Archives and Records Administration at the following Internet
address: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html.
The following additional requirements apply to this project:
AR-1 Human Subjects Requirements
AR-2 Requirements for Inclusion of Women and racial and Ethnic
Minorities in Research
AR-9 Paperwork Reduction Act Requirements Projects that involve the
collection of information from ten or more persons and that are funded
by cooperative agreements will be subject to review and approval by the
Office of Management and Budget (OMB).
AR-10 Smoke-Free Workplace Requirements
AR-11 Healthy People 2010
AR-12 Lobbying Restrictions
AR-13 Prohibition on Use of CDC Funds for Certain Gun Control
Activities
AR-21 Small, Minority, Women-Owned Businesses
AR-22 Research Integrity
AR-23 States and Faith-Based Organizations
AR-24 Health Insurance Portability and Accountability Requirements
AR-25 Release and Sharing of Data
Starting with the December 1, 2003 receipt date, all NCIPC funded
investigators seeking more than $250,000 in total costs in a single
year are expected to include a plan describing how the final research
data will be shared/released or explain why data sharing is not
possible. Details on data sharing/release, including the timeliness and
name of the project data steward, should be included in a brief
paragraph immediately following the Research Plan Section of the PHS
398 form. References to data sharing/release may also be appropriate in
other sections of the application (e.g. background and significance,
human subjects requirements, etc.) The content of the data sharing/
release plan will vary, depending on the data being collected and how
the investigator is planning to share the data. The data sharing/
release plan will not count towards the application page limit and will
not factor into the determination scientific merit or priority scores.
Investigators should seek guidance from their institutions, on issues
related to institutional policies, local IRB rules, as well as local,
state and Federal laws and regulations, including the Privacy Rule.
Further detail on the requirements for addressing data sharing in
applications for NCIPC funding may be obtained by contacting NCIPC
program staff or visiting the NCIPC Internet Web site: at http://www.cdc.gov/ncipc/osp/sharing_policy.htm
.
Additional information on these requirements can be found on the
CDC
[[Page 66834]]
Web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/ARs.htm
.
3. Reporting: You must provide the CDC with original and two copies
of the following reports:
1. Interim progress report (PHS 2590, OMB Number 0925-0001, rev. 5/
2001) no less than 90 days before the end of the budget period. The
progress report will serve as your non-competing continuation
application, and must contain the following elements:
a. Current Budget Period Activities Objectives
b. Current Budget Period Financial Progress.
c. New Budget Period Program Proposed Activity Objectives.
d. Detailed Line-Item Budget and Justification.
e. Additional Requested Information.
2. Financial status report, no more than 90 days after the end of
the budget period.
3. Final financial status and performance reports, no more than 90
days after the end of the project period.
VII. Agency Contacts
For general questions about this announcement, contact: Technical
Information Management Section, Procurement and Grants Office, Centers
for Disease Control and Prevention, 2920 Brandywine Road, Atlanta, GA
30341-4146, Telephone: (770) 488-2700.
For questions about scientific/research program technical issues
contact, Marci Feldman, M.S., Project Officer, Division of Violence
Prevention, National Center for Injury Prevention and Control, Centers
for Disease Control and Prevention, 4770 Buford Highway, NE MS K-60,
Atlanta, GA 30341, Telephone: (770) 488-4478. FAX: (770) 488-4349. Email: MFeldman@cdc.gov.
For questions about peer review issues, contact, Gwen Cattledge,
Scientific Review Administrator, National Center for Injury Prevention
and Control, Centers for Disease Control and Prevention, 4770 Buford
Hwy, NE, Mailstop K-02, Atlanta, GA 30341, Telephone: 770-488-1430. Email: gxc8@cdc.gov.
For budget assistance, contact: James Masone, Contracts Specialist,
Procurement and Grants Office, Centers for Disease Control and
Prevention, 2920 Brandywine Road, Atlanta, GA 30341-4146, Telephone: 770-488-2736. FAX: 770-488-2671. Email: zft2@cdc.gov.
VIII. Other Information
References:
1. National Center for Injury Prevention and Control. CDC Injury
Research Agenda. Atlanta, GA: Centers for Disease Control and
new millennium. Menlo Park, CA: Henry J. Kaiser Family Foundation,
1999.
3. Woodward EH. Media in the home 2000: The fourth annual survey of
parents and children (Survey Series No. 7). Philadelphia, PA: The
Annenberg Public Policy Center of the University of Pennsylvania, 1998.
4. Wilson BJ, Kunkel D, Linz D, Potter J, Donnerstein E, Smith SL,
Blumenthal E, Gray T. Violence in television programming overall:
University of California, Santa Barbara study. In Seawall M. (Ed.),
National television violence study (Vol. 1, pp. 3-184). Thousand Oaks,
CA: Sage Publications, 1997.
Wilson BJ, Kunkel D, Linz D, Potter J, Donnerstein E, Smith SL,
Blumenthal E, Berry M. Violence in television programming overall:
University of California, Santa Barbara study. In Seawall M. (Ed.),
National television violence study (Vol. 2, pp. 3-204). Thousand Oaks,
CA: Sage Publications, 1998.
Dated: November 20, 2003.
Edward Schultz,
Acting Director, Procurement and Grants Office, Centers for Disease
Control and Prevention.
[FR Doc. 03-29632 Filed 11-26-03; 8:45 am]
BILLING CODE 4163-18-P